GAMA
BLUE

Graticule Asia Macro Advisors’s bluebird bio BLUE Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,102
Closed -$4.28M – 102
2019
Q1 		$4.28M Buy
+2,102
New +$3.7M 0.3% 72
2017
Q1 		– Sell
-556
Closed -$444K – 129
2016
Q4 		$444K Buy
+556
New +$442K 0.05% 92

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Graticule Asia Macro Advisors's BLUE Position: Q2 2019 in Review

Graticule Asia Macro Advisors sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 2,102 shares — an estimated $4.28M sold.

Graticule Asia Macro Advisors first reported a position in BLUE in Q4 2016 and held it in 2 quarters. The position peaked at $4.28M in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Graticule Asia Macro Advisors reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 2,102 bluebird bio shares in Q2 2019, an estimated $4.28M.
  • Graticule Asia Macro Advisors first reported a position in bluebird bio in Q4 2016 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's bluebird bio position peaked at $4.28M in Q1 2019.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.